Ulrike Kirsten Buchwald, M.D., M.S.

Headshot of Ulrike Kirsten Buchwald
  • Assistant Professor of Medicine
Female

Languages: English, German

Expertise

Anal Cancer, Anal Dysplasia, HPV-Related Anogenital Disease ...read more

Research Interests

Anal Dysplasia; Anal Cancer; Cancer Screening Program ...read more

Background

Ulrike Kirsten Buchwald is an infectious diseases and HIV physician who attended Medical School in Germany and completed training in internal medicine residency and infectious diseases at New York University.  In 2010, she joined the University of Maryland School of Medicine, Division of Infectious Diseases and the Institute of Human Virology.

Dr. Buchwald received training in anal cancer screening and high-resolution anoscopy (HRA) and started a dedicated anal cancer screening clinic known as the Anal Lesion Evaluation Research Treatment (ALERT) clinic at the University of Maryland. She was the director of the ALERT clinic and in 2017 co-founded the Maryland Consortium for Anal Cancer Screening (MCACS) with Dr. Joyce Jones, Johns Hopkins Department of Medicine, and colleagues from the Department of Colorectal Surgery, to strengthen clinical care and research for HPV-related anal disease. She joined the Division of Gastroenterology and Hepatology at Johns Hopkins in 2019 to build a multi-disciplinary team dedicated to anal cancer screening, and to increase access to high-resolution anoscopy services and HPV-related anal dysplasia treatment for high-risk patients in Baltimore and the region.

...read more

Titles

  • Assistant Professor of Medicine

Departments / Divisions

Education

Degrees

  • MD; Freie Universitat Berlin (1998)

Residencies

  • Internal Medicine; NYU Langone Medical Center (2007)

Fellowships

  • Infectious Diseases; NYU Langone Medical Center (2010)

Board Certifications

  • American Board of Internal Medicine (Infectious Disease) (2010)
  • American Board of Internal Medicine (Internal Medicine) (2007)

Research & Publications

Research Summary

Dr. Buchwald's research interests include the acceptance and impact of anal cancer screening, design of cancer screening programs, and the natural history of HPV related anal dysplasia in high-risk populations.

Selected Publications

View all on PubMed

Fang SH, Plesa M, Carchman EH, Cowell NA, Staudt E, Twaroski KA, Buchwald UK, Trimble CL. 2023. A phase I study of intra-anal artesunate (suppositories) to treat anal high-grade squamous intraepithelial lesions. PLoS One. 18(12):e0295647. doi: 10.1371/journal.pone.0295647. PMID: 38100463

Bull-Henry K, Morris B, Buchwald UK. 2020. The importance of anal cancer screening and high-resolution anoscopy to gastroenterologic practice. Curr Opin Gastroenterol; 36: 393-401

Sowah LA, Schmalzle SA, Khambaty M, Buchwald UK, 2020, Establishing an Anal Cancer Screening Program in an Outpatient HIV Clinic: Referral Patterns and Patient Perceptions Survey. J Int Assoc Provid AIDS Care. 19: 1-5

Chen S, Leeds IL, Cerullo M, Jones JL, Buchwald UK, Efron, JE, Gearhart SL, Safar B, Fang SH. 2019. Anal Cancer Screening Attitudes and Practices in Maryland Healthcare Providers: Implications for National Trends. J Surg Oncol, 2(3): 2-7

Sowah LA, Buchwald UK, Riedel DJ, Gilliam BL, Khambaty M, Fantry L, Weaver J, Spencer DE, Skoglund M, Taylor G, Amoroso A, Redfield RR. 2015. Anal cancer screening in an urban HIV clinic - Provider perceptions and practice. J Int As soc Provid AIDS Care. 14(6):497-504. doi: 10.1177/2325957415601504. Epub 2015 Aug 25

Contact for Research Inquiries

Email me

Activities & Honors

Memberships

  • IANS

    International Anal Neoplasia Society

  • IDSA

    Infectious Diseases Society of America

  • HIVMA

    HIV Medicine Association

Videos & Media

Recent News Articles and Media Coverage

Making Anal Cancer Screening a Priority for High-Risk Patients Hopkins Medicine

Is this you? Edit Profile
back to top button